Johnson & Johnson

Company Profile

Johnson & Johnson had its IPO on 1944-09-24 under the ticker symbol JNJ.

The company operates in the Healthcare sector and Drug Manufacturers-General industry. Johnson & Johnson has a staff strength of 152,700 employees.

Stock update

Shares of Johnson & Johnson opened at $162.22 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $161.54 - $163.93, and closed at $163.58.

This is a +0.57% increase from the previous day's closing price.

A total volume of 5,026,427 shares were traded at the close of the day’s session.

In the last one week, shares of Johnson & Johnson have increased by +1.93%.

Johnson & Johnson's Key Ratios

Johnson & Johnson has a market cap of $391.69 billion, indicating a price to book ratio of 6.1592 and a price to sales ratio of 4.8935.

In the last 12-months Johnson & Johnson’s revenue was $97.77 billion with a gross profit of $63.95 billion and an EBITDA of $34.31 billion. The EBITDA ratio measures Johnson & Johnson's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Johnson & Johnson’s operating margin was 27.66% while its return on assets stood at 9.15% with a return of equity of 17.09%.

In Q2, Johnson & Johnson’s quarterly earnings growth was a positive 8.9% while revenue growth was a positive 6.3%.

Johnson & Johnson’s PE and PEG Ratio

Forward PE

16.8919

Trailing PE

32.9939

PEG

3.7929

Its diluted EPS in the last 12-months stands at $4.93 per share while it has a forward price to earnings multiple of 16.8919 and a PEG multiple of 3.7929. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Johnson & Johnson’s profitability.

Johnson & Johnson stock is trading at a EV to sales ratio of 4.7627 and a EV to EBITDA ratio of 15.4742. Its price to sales ratio in the trailing 12-months stood at 4.8935.

Johnson & Johnson stock pays annual dividends of $4.58 per share, indicating a yield of 2.93% and a payout ratio of 44.7%.

Balance sheet and cash flow metrics

Total Assets

$191.69 billion

Total Liabilities

$54.17 billion

Operating Cash Flow

$-461000000.00

Capital Expenditure

$1.12 billion

Dividend Payout Ratio

44.7%

Johnson & Johnson ended 2024 with $191.69 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $191.69 billion while shareholder equity stood at $75.15 billion.

Johnson & Johnson ended 2024 with $0 in deferred long-term liabilities, $54.17 billion in other current liabilities, 3120000000.00 in common stock, $129.38 billion in retained earnings and $45.44 billion in goodwill. Its cash balance stood at $21.18 billion and cash and short-term investments were $28.51 billion. The company’s total short-term debt was $11,701,000,000 while long-term debt stood at $33.90 billion.

Johnson & Johnson’s total current assets stands at $60.57 billion while long-term investments were $0 and short-term investments were $7.32 billion. Its net receivables were $16.78 billion compared to accounts payable of $10.44 billion and inventory worth $12.89 billion.

In 2024, Johnson & Johnson's operating cash flow was $-461000000.00 while its capital expenditure stood at $1.12 billion.

Comparatively, Johnson & Johnson paid $0.45 in dividends in 2024.

Other key metrics

Current Trading Price

$163.58

52-Week High

$177.1152

52-Week Low

$147.9119

Analyst Target Price

$182.76

Johnson & Johnson stock is currently trading at $163.58 per share. It touched a 52-week high of $177.1152 and a 52-week low of $177.1152. Analysts tracking the stock have a 12-month average target price of $182.76.

Its 50-day moving average was $165.24 and 200-day moving average was $162.46 The short ratio stood at 3.41 indicating a short percent outstanding of 0%.

Around 9.7% of the company’s stock are held by insiders while 7079.4% are held by institutions.